Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04866901 · ClinicalTrials.gov registry record · NA

Interactive Effects of Mindfulness and Slow-paced Breathing

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT04866901: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.

NCT04866901 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04866901, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The purpose of this study is to better understand specific stress-management practices on mood, sleep, and physiology. Participants will be assigned to one of three interventions (they all active interventions - none are a "wait-list"). Each intervention asks participants to engage in a daily practice of 20 minutes per day for 8 weeks. Questionnaires and measures of heart rate and blood pressure will be collected at the start and end of the 8 weeks, including a virtual laboratory visit.

Primary Outcome

Participants will wear a Polar H10 chest strap heart rate monitor during training and daily practice, and breathing rate will be derived from the HR interbeat interval series. We expect participants randomized to SPB and SPB+M to show slower breathing rates compared to M during a recorded practice session at 8-weeks.

Interventions

  • BEHAVIORAL Slow-Paced Breathing (SPB)
  • BEHAVIORAL Mindfulness (M)
  • BEHAVIORAL Yogic Breathing (SPB+M)

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-05-14
Est. Completion 2021-09-30
Phase NA

What the finished NCT04866901 record still lists

NCT04866901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Slow-Paced Breathing (SPB) is the first listed.

NCT04866901 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04866901 about?

NCT04866901 is a clinical study titled "Interactive Effects of Mindfulness and Slow-paced Breathing". The purpose of this study is to better understand specific stress-management practices on mood, sleep, and physiology. Participants will be assigned to one of three interventions (they all active interventions - none are a "wait-list"). Each intervention asks participants to engage in a daily practi...

What is the current status of trial NCT04866901?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-05-14. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT04866901?

The interventions under investigation include: Slow-Paced Breathing (SPB) (BEHAVIORAL), Mindfulness (M) (BEHAVIORAL), Yogic Breathing (SPB+M) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04866901?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04866901's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04866901, the US trial registry maintained by the National Library of Medicine. NCT04866901 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.